RIPK3 serve as a crucial mediator in the necroptosis pathway (He et al, 2009), impacting liver cancer progression and chemotherapy-induced immunogenic cell death, with its expression levels correlating with immune infiltration in breast cancer tissues (Stoll et al, 2017; Yang et al, 2016). This evidence concerns the gene RIPK3 and breast cancer.